CN103305538A - 枸杞细胞质抗坏血酸过氧化物酶基因及应用 - Google Patents
枸杞细胞质抗坏血酸过氧化物酶基因及应用 Download PDFInfo
- Publication number
- CN103305538A CN103305538A CN2013101739853A CN201310173985A CN103305538A CN 103305538 A CN103305538 A CN 103305538A CN 2013101739853 A CN2013101739853 A CN 2013101739853A CN 201310173985 A CN201310173985 A CN 201310173985A CN 103305538 A CN103305538 A CN 103305538A
- Authority
- CN
- China
- Prior art keywords
- lmapx
- gene
- ascorbate peroxidase
- peroxidase gene
- cytoplasmic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108060006004 Ascorbate peroxidase Proteins 0.000 title claims abstract description 31
- 235000015468 Lycium chinense Nutrition 0.000 title abstract description 8
- 244000241872 Lycium chinense Species 0.000 title description 3
- 210000000805 cytoplasm Anatomy 0.000 title description 2
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 49
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 33
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 33
- 239000013598 vector Substances 0.000 claims abstract description 29
- 241000196324 Embryophyta Species 0.000 claims abstract description 22
- 241000588724 Escherichia coli Species 0.000 claims abstract description 18
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 18
- 239000013604 expression vector Substances 0.000 claims abstract description 18
- 230000014509 gene expression Effects 0.000 claims abstract description 10
- 239000002773 nucleotide Substances 0.000 claims abstract description 7
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 7
- 230000009261 transgenic effect Effects 0.000 claims abstract description 6
- 244000061176 Nicotiana tabacum Species 0.000 claims abstract 3
- 102000004169 proteins and genes Human genes 0.000 claims description 18
- 239000013612 plasmid Substances 0.000 claims description 10
- 239000012634 fragment Substances 0.000 claims description 6
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- CWHJIJJSDGEHNS-MYLFLSLOSA-N Senegenin Chemical compound C1[C@H](O)[C@H](O)[C@@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)C(CC[C@]4(CCC(C[C@H]44)(C)C)C(O)=O)=C4[C@@H](CCl)C[C@@H]3[C@]21C CWHJIJJSDGEHNS-MYLFLSLOSA-N 0.000 claims 5
- 239000009871 tenuigenin Substances 0.000 claims 5
- 244000068988 Glycine max Species 0.000 claims 2
- 235000010469 Glycine max Nutrition 0.000 claims 2
- 240000008042 Zea mays Species 0.000 claims 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims 2
- 235000018102 proteins Nutrition 0.000 claims 2
- 235000017060 Arachis glabrata Nutrition 0.000 claims 1
- 244000105624 Arachis hypogaea Species 0.000 claims 1
- 235000010777 Arachis hypogaea Nutrition 0.000 claims 1
- 235000018262 Arachis monticola Nutrition 0.000 claims 1
- 208000003643 Callosities Diseases 0.000 claims 1
- 229920000742 Cotton Polymers 0.000 claims 1
- 241000219146 Gossypium Species 0.000 claims 1
- 244000020551 Helianthus annuus Species 0.000 claims 1
- 235000003222 Helianthus annuus Nutrition 0.000 claims 1
- 240000005979 Hordeum vulgare Species 0.000 claims 1
- 235000007340 Hordeum vulgare Nutrition 0.000 claims 1
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 244000062793 Sorghum vulgare Species 0.000 claims 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 235000005822 corn Nutrition 0.000 claims 1
- 235000009973 maize Nutrition 0.000 claims 1
- 235000019713 millet Nutrition 0.000 claims 1
- 235000020232 peanut Nutrition 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 235000013311 vegetables Nutrition 0.000 claims 1
- 230000001086 cytosolic effect Effects 0.000 abstract description 25
- 238000000034 method Methods 0.000 abstract description 14
- 241000589158 Agrobacterium Species 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 11
- 102000004190 Enzymes Human genes 0.000 abstract description 10
- 108090000790 Enzymes Proteins 0.000 abstract description 10
- 238000010367 cloning Methods 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- 238000011160 research Methods 0.000 abstract description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 48
- 235000010323 ascorbic acid Nutrition 0.000 description 23
- 239000011668 ascorbic acid Substances 0.000 description 23
- 229960005070 ascorbic acid Drugs 0.000 description 23
- 102100037373 DNA-(apurinic or apyrimidinic site) endonuclease Human genes 0.000 description 22
- 238000006243 chemical reaction Methods 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 15
- 241000208125 Nicotiana Species 0.000 description 15
- 239000002609 medium Substances 0.000 description 15
- 239000000047 product Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- 230000001580 bacterial effect Effects 0.000 description 10
- 238000011144 upstream manufacturing Methods 0.000 description 10
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 7
- 108010050848 glycylleucine Proteins 0.000 description 6
- 229930027917 kanamycin Natural products 0.000 description 6
- 229960000318 kanamycin Drugs 0.000 description 6
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 6
- 229930182823 kanamycin A Natural products 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 108010092854 aspartyllysine Proteins 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 108010015796 prolylisoleucine Proteins 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 230000009182 swimming Effects 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108010077805 Bacterial Proteins Proteins 0.000 description 3
- 102100031780 Endonuclease Human genes 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 210000003763 chloroplast Anatomy 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- YHKANGMVQWRMAP-DCAQKATOSA-N Ala-Leu-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YHKANGMVQWRMAP-DCAQKATOSA-N 0.000 description 2
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 2
- WQLDNOCHHRISMS-NAKRPEOUSA-N Ala-Pro-Ile Chemical compound [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WQLDNOCHHRISMS-NAKRPEOUSA-N 0.000 description 2
- YJHKTAMKPGFJCT-NRPADANISA-N Ala-Val-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O YJHKTAMKPGFJCT-NRPADANISA-N 0.000 description 2
- OANWAFQRNQEDSY-DCAQKATOSA-N Arg-Cys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCN=C(N)N)N OANWAFQRNQEDSY-DCAQKATOSA-N 0.000 description 2
- XLWSGICNBZGYTA-CIUDSAMLSA-N Arg-Glu-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O XLWSGICNBZGYTA-CIUDSAMLSA-N 0.000 description 2
- KZXPVYVSHUJCEO-ULQDDVLXSA-N Arg-Phe-Lys Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CC=CC=C1 KZXPVYVSHUJCEO-ULQDDVLXSA-N 0.000 description 2
- NGYHSXDNNOFHNE-AVGNSLFASA-N Arg-Pro-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O NGYHSXDNNOFHNE-AVGNSLFASA-N 0.000 description 2
- PCKRJVZAQZWNKM-WHFBIAKZSA-N Asn-Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O PCKRJVZAQZWNKM-WHFBIAKZSA-N 0.000 description 2
- YVHGKXAOSVBGJV-CIUDSAMLSA-N Asp-Lys-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)O)N YVHGKXAOSVBGJV-CIUDSAMLSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 229930186147 Cephalosporin Natural products 0.000 description 2
- NIPJKKSXHSBEMX-CIUDSAMLSA-N Cys-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)N NIPJKKSXHSBEMX-CIUDSAMLSA-N 0.000 description 2
- CLEFUAZULXANBU-MELADBBJSA-N Cys-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CS)N)C(=O)O CLEFUAZULXANBU-MELADBBJSA-N 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- BJPPYOMRAVLXBY-YUMQZZPRSA-N Gln-Met-Gly Chemical compound CSCC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N BJPPYOMRAVLXBY-YUMQZZPRSA-N 0.000 description 2
- OZEQPCDLCDRCGY-SOUVJXGZSA-N Gln-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(=O)N)N)C(=O)O OZEQPCDLCDRCGY-SOUVJXGZSA-N 0.000 description 2
- PXHABOCPJVTGEK-BQBZGAKWSA-N Glu-Gln-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O PXHABOCPJVTGEK-BQBZGAKWSA-N 0.000 description 2
- BUAKRRKDHSSIKK-IHRRRGAJSA-N Glu-Glu-Tyr Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 BUAKRRKDHSSIKK-IHRRRGAJSA-N 0.000 description 2
- ATVYZJGOZLVXDK-IUCAKERBSA-N Glu-Leu-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O ATVYZJGOZLVXDK-IUCAKERBSA-N 0.000 description 2
- MWMJCGBSIORNCD-AVGNSLFASA-N Glu-Leu-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O MWMJCGBSIORNCD-AVGNSLFASA-N 0.000 description 2
- SWRVAQHFBRZVNX-GUBZILKMSA-N Glu-Lys-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O SWRVAQHFBRZVNX-GUBZILKMSA-N 0.000 description 2
- FKJQNJCQTKUBCD-XPUUQOCRSA-N Gly-Ala-His Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O FKJQNJCQTKUBCD-XPUUQOCRSA-N 0.000 description 2
- OVSKVOOUFAKODB-UWVGGRQHSA-N Gly-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OVSKVOOUFAKODB-UWVGGRQHSA-N 0.000 description 2
- WDXLKVQATNEAJQ-BQBZGAKWSA-N Gly-Pro-Asp Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O WDXLKVQATNEAJQ-BQBZGAKWSA-N 0.000 description 2
- IXHQLZIWBCQBLQ-STQMWFEESA-N Gly-Pro-Phe Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IXHQLZIWBCQBLQ-STQMWFEESA-N 0.000 description 2
- ISSDODCYBOWWIP-GJZGRUSLSA-N Gly-Pro-Trp Chemical compound [H]NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O ISSDODCYBOWWIP-GJZGRUSLSA-N 0.000 description 2
- BXDLTKLPPKBVEL-FJXKBIBVSA-N Gly-Thr-Met Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(O)=O BXDLTKLPPKBVEL-FJXKBIBVSA-N 0.000 description 2
- FOKISINOENBSDM-WLTAIBSBSA-N Gly-Thr-Tyr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O FOKISINOENBSDM-WLTAIBSBSA-N 0.000 description 2
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 2
- KZTLOHBDLMIFSH-XVYDVKMFSA-N His-Ala-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O KZTLOHBDLMIFSH-XVYDVKMFSA-N 0.000 description 2
- YADRBUZBKHHDAO-XPUUQOCRSA-N His-Gly-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](C)C(O)=O YADRBUZBKHHDAO-XPUUQOCRSA-N 0.000 description 2
- QCBYAHHNOHBXIH-UWVGGRQHSA-N His-Pro-Gly Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)C1=CN=CN1 QCBYAHHNOHBXIH-UWVGGRQHSA-N 0.000 description 2
- KAXZXLSXFWSNNZ-XVYDVKMFSA-N His-Ser-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KAXZXLSXFWSNNZ-XVYDVKMFSA-N 0.000 description 2
- FVEWRQXNISSYFO-ZPFDUUQYSA-N Ile-Arg-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N FVEWRQXNISSYFO-ZPFDUUQYSA-N 0.000 description 2
- GVKKVHNRTUFCCE-BJDJZHNGSA-N Ile-Leu-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)N GVKKVHNRTUFCCE-BJDJZHNGSA-N 0.000 description 2
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 2
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 2
- HXWALXSAVBLTPK-NUTKFTJISA-N Leu-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(C)C)N HXWALXSAVBLTPK-NUTKFTJISA-N 0.000 description 2
- REPPKAMYTOJTFC-DCAQKATOSA-N Leu-Arg-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O REPPKAMYTOJTFC-DCAQKATOSA-N 0.000 description 2
- KSZCCRIGNVSHFH-UWVGGRQHSA-N Leu-Arg-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O KSZCCRIGNVSHFH-UWVGGRQHSA-N 0.000 description 2
- KTFHTMHHKXUYPW-ZPFDUUQYSA-N Leu-Asp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KTFHTMHHKXUYPW-ZPFDUUQYSA-N 0.000 description 2
- RRSLQOLASISYTB-CIUDSAMLSA-N Leu-Cys-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(O)=O RRSLQOLASISYTB-CIUDSAMLSA-N 0.000 description 2
- OGUUKPXUTHOIAV-SDDRHHMPSA-N Leu-Glu-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N OGUUKPXUTHOIAV-SDDRHHMPSA-N 0.000 description 2
- DBSLVQBXKVKDKJ-BJDJZHNGSA-N Leu-Ile-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O DBSLVQBXKVKDKJ-BJDJZHNGSA-N 0.000 description 2
- JNDYEOUZBLOVOF-AVGNSLFASA-N Leu-Leu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JNDYEOUZBLOVOF-AVGNSLFASA-N 0.000 description 2
- ZRHDPZAAWLXXIR-SRVKXCTJSA-N Leu-Lys-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O ZRHDPZAAWLXXIR-SRVKXCTJSA-N 0.000 description 2
- CHJKEDSZNSONPS-DCAQKATOSA-N Leu-Pro-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O CHJKEDSZNSONPS-DCAQKATOSA-N 0.000 description 2
- IZPVWNSAVUQBGP-CIUDSAMLSA-N Leu-Ser-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IZPVWNSAVUQBGP-CIUDSAMLSA-N 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- KCXUCYYZNZFGLL-SRVKXCTJSA-N Lys-Ala-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O KCXUCYYZNZFGLL-SRVKXCTJSA-N 0.000 description 2
- SJNZALDHDUYDBU-IHRRRGAJSA-N Lys-Arg-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(O)=O SJNZALDHDUYDBU-IHRRRGAJSA-N 0.000 description 2
- WGCKDDHUFPQSMZ-ZPFDUUQYSA-N Lys-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCCCN WGCKDDHUFPQSMZ-ZPFDUUQYSA-N 0.000 description 2
- DRCILAJNUJKAHC-SRVKXCTJSA-N Lys-Glu-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O DRCILAJNUJKAHC-SRVKXCTJSA-N 0.000 description 2
- GCMWRRQAKQXDED-IUCAKERBSA-N Lys-Glu-Gly Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)N[C@@H](CCC([O-])=O)C(=O)NCC([O-])=O GCMWRRQAKQXDED-IUCAKERBSA-N 0.000 description 2
- PINHPJWGVBKQII-SRVKXCTJSA-N Lys-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCCN)N PINHPJWGVBKQII-SRVKXCTJSA-N 0.000 description 2
- CNGOEHJCLVCJHN-SRVKXCTJSA-N Lys-Pro-Glu Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O CNGOEHJCLVCJHN-SRVKXCTJSA-N 0.000 description 2
- JHNOXVASMSXSNB-WEDXCCLWSA-N Lys-Thr-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JHNOXVASMSXSNB-WEDXCCLWSA-N 0.000 description 2
- JACAKCWAOHKQBV-UWVGGRQHSA-N Met-Gly-Lys Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN JACAKCWAOHKQBV-UWVGGRQHSA-N 0.000 description 2
- PZUUMQPMHBJJKE-AVGNSLFASA-N Met-Leu-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCNC(N)=N PZUUMQPMHBJJKE-AVGNSLFASA-N 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- CYZBFPYMSJGBRL-DRZSPHRISA-N Phe-Ala-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CYZBFPYMSJGBRL-DRZSPHRISA-N 0.000 description 2
- WMGVYPPIMZPWPN-SRVKXCTJSA-N Phe-Asp-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N WMGVYPPIMZPWPN-SRVKXCTJSA-N 0.000 description 2
- RGMLUHANLDVMPB-ULQDDVLXSA-N Phe-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N RGMLUHANLDVMPB-ULQDDVLXSA-N 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 244000203593 Piper nigrum Species 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- CQZNGNCAIXMAIQ-UBHSHLNASA-N Pro-Ala-Phe Chemical compound C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O CQZNGNCAIXMAIQ-UBHSHLNASA-N 0.000 description 2
- UTAUEDINXUMHLG-FXQIFTODSA-N Pro-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 UTAUEDINXUMHLG-FXQIFTODSA-N 0.000 description 2
- SUENWIFTSTWUKD-AVGNSLFASA-N Pro-Leu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O SUENWIFTSTWUKD-AVGNSLFASA-N 0.000 description 2
- KBUAPZAZPWNYSW-SRVKXCTJSA-N Pro-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KBUAPZAZPWNYSW-SRVKXCTJSA-N 0.000 description 2
- 108010079005 RDV peptide Proteins 0.000 description 2
- MIJWOJAXARLEHA-WDSKDSINSA-N Ser-Gly-Glu Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O MIJWOJAXARLEHA-WDSKDSINSA-N 0.000 description 2
- JFWDJFULOLKQFY-QWRGUYRKSA-N Ser-Gly-Phe Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JFWDJFULOLKQFY-QWRGUYRKSA-N 0.000 description 2
- ZVBCMFDJIMUELU-BZSNNMDCSA-N Ser-Tyr-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)N ZVBCMFDJIMUELU-BZSNNMDCSA-N 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- DFTCYYILCSQGIZ-GCJQMDKQSA-N Thr-Ala-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DFTCYYILCSQGIZ-GCJQMDKQSA-N 0.000 description 2
- RFKVQLIXNVEOMB-WEDXCCLWSA-N Thr-Leu-Gly Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N)O RFKVQLIXNVEOMB-WEDXCCLWSA-N 0.000 description 2
- JLNMFGCJODTXDH-WEDXCCLWSA-N Thr-Lys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O JLNMFGCJODTXDH-WEDXCCLWSA-N 0.000 description 2
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 2
- TWAVEIJGFCBWCG-JYJNAYRXSA-N Tyr-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N TWAVEIJGFCBWCG-JYJNAYRXSA-N 0.000 description 2
- HIZMLPKDJAXDRG-FXQIFTODSA-N Val-Cys-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)N HIZMLPKDJAXDRG-FXQIFTODSA-N 0.000 description 2
- ZXAGTABZUOMUDO-GVXVVHGQSA-N Val-Glu-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N ZXAGTABZUOMUDO-GVXVVHGQSA-N 0.000 description 2
- QIVPZSWBBHRNBA-JYJNAYRXSA-N Val-Pro-Phe Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O QIVPZSWBBHRNBA-JYJNAYRXSA-N 0.000 description 2
- YQYFYUSYEDNLSD-YEPSODPASA-N Val-Thr-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O YQYFYUSYEDNLSD-YEPSODPASA-N 0.000 description 2
- 108010005233 alanylglutamic acid Proteins 0.000 description 2
- 108010047495 alanylglycine Proteins 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 108010077245 asparaginyl-proline Proteins 0.000 description 2
- 108010093581 aspartyl-proline Proteins 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 108010025306 histidylleucine Proteins 0.000 description 2
- 108010092114 histidylphenylalanine Proteins 0.000 description 2
- 108010078274 isoleucylvaline Proteins 0.000 description 2
- 108010009932 leucyl-alanyl-glycyl-valine Proteins 0.000 description 2
- 108010051673 leucyl-glycyl-phenylalanine Proteins 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 108010018625 phenylalanylarginine Proteins 0.000 description 2
- 238000000751 protein extraction Methods 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 239000012882 rooting medium Substances 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 108010048818 seryl-histidine Proteins 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 108010029384 tryptophyl-histidine Proteins 0.000 description 2
- 108700026220 vif Genes Proteins 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 108050006227 Haem peroxidases Proteins 0.000 description 1
- 108010089792 Hemeproteins Proteins 0.000 description 1
- 102000008015 Hemeproteins Human genes 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- SXZYCXMUPBBULW-SKNVOMKLSA-N L-gulono-1,4-lactone Chemical compound OC[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O SXZYCXMUPBBULW-SKNVOMKLSA-N 0.000 description 1
- 108700005084 Multigene Family Proteins 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000002500 microbody Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 235000007352 monodehydroascorbic acid Nutrition 0.000 description 1
- 239000011744 monodehydroascorbic acid Substances 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000006950 reactive oxygen species formation Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 230000008653 root damage Effects 0.000 description 1
- 230000002786 root growth Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000002377 thylakoid Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明涉及一种枸杞细胞质抗坏血酸过氧化物酶基因及应用。它具有SEQ ID No.1序列所示的核苷酸序列;通过提取新鲜枸杞叶片总RNA,通过同源克隆的策略和3'RACE技术克隆枸杞细胞质抗坏血酸过氧化物酶基因LmAPX,得到完整的编码基因序列为753bp。构建了大肠杆菌表达载体pET28a-Lm APX,应用大肠杆菌异源表达系统,对克隆的枸杞细胞质抗坏血酸过氧化物酶基因LmAPX编码的酶活性进行了鉴定,该重组蛋白对底物抗坏血酸(AsA)和H2O2都具有较高的活性。同时构建了双元植物表达载体pCAMBIA2300-LmAPX,电击法将载体转入农杆菌C58细胞,用这种细胞转化烟草,得到转基因烟草,用于后续的逆境胁迫研究。
Description
技术领域
本发明涉及一种枸杞(Lycium chinense Miller)细胞质中抗坏血酸过氧化物酶基因LmAPX的克隆,具体为一种枸杞细胞质抗坏血酸过氧化物酶基因及应用。
背景技术
抗坏血酸过氧化物酶(Ascorbate peroxidase,APX,EC1.11.1.11)是一种亚铁血红素蛋白,也叫做维生素C过氧化物酶,它属于末端氧化酶的一种,主要存在于高等植物、真核藻类及某些蓝细菌中,但在某些昆虫中也检测到该酶活性。APX是清除H2O2的关键酶,以还原型抗坏血酸为反应底物,它催化H2O2还原为H2O的反应,对抗坏血酸具有很高的特异性和亲和性,消耗H2O2产生单脱氢抗坏血酸,单脱氢抗坏血酸可通过不同的途径被还原成抗坏血酸(AsAda, 1992; Shigeoka et al.,1980a; 1980b)。在高等植物中,APX是一个多基因家族,根据其在细胞内的定位不同可分为:叶绿体中的基质APX(sAPX)、类囊体膜APX(tAPX)、微体(乙醛酸循环体和过氧化物酶体)膜结合型APX(mAPX)、胞质APX(cAPX)和线粒体APX(mitAPX)。
APX的分子和酶学特点不同于其它的血红素过氧化物酶。APX对电子供体AsA具有高度的特异性,尤其是叶绿体APX(chlAPX)和mitAPX。APX的一个最大特点是在没有电子供体AsA时很不稳定,AsA低于20μmol/L时APX的活性迅速降低,适当内源浓度的AsA(≥20 mol/L)对于APX作用的发挥至关重要,这不仅表明AsA可以调节APX的活性,而且为AsA作为植物重要的抗氧化剂提供了证据。
在逆境条件(盐渍、干旱、高温、低温、真菌侵染等)下,植物由于细胞代谢过程不协调会导致各种活性氧的升高从而造成氧化胁迫。氧化胁迫是由ROS,如单线态的氧、超氧负离子、过氧化氢及羟自由基的形成导致的。过量的ROS对植物细胞具有较强的毒害作用,使细胞产生细胞水平和分子水平上的不可逆损伤,膜系统遭到破坏,导致组织结构和细胞区隔化丧失,胞膜系统产生变性,最终导致细胞损伤和死亡。APX在植物生长发育和逆境胁迫响应等生理过程中都发挥着非常重要的作用,尤其是植物受到逆境胁迫时,APX可以快速清除细胞中产生的过量的H2O2,对于保护叶绿体和其他细胞组分免受H2O2及其所产生的羟自由基的破坏是必不可少的。APX能提高氧化耐受性的作用已在许多植物中有报道,目前多种植物的APX基因已克隆并应用于植物转基因的研究(孙卫红等,2005)。由于APX在清除ROS、抵抗逆境胁迫方面具有重要作用,植物体内主要的过氧化物清除酶APX已成为当今植物耐逆性研究中的一个热点。
发明内容
本发明的目的在于提供一种枸杞细胞质抗坏血酸过氧化物酶基因。
本发明的第二个目的是提供该基因编码的蛋白质。
本发明的目的还在于提供含有该基因的重组载体和宿主细胞。
本发明的另一个目的在于提供该基因的用途。
本发明提供了一种枸杞细胞质抗坏血酸过氧化物酶基因LmAPX,如序列表中SEQ ID NO.1所示的核苷酸序列构成。
本发明提供了一种上述枸杞细胞质抗坏血酸过氧化物酶基因LmAPX编码的蛋白质,如序列表中SEQ ID NO.2所示的氨基酸序列的蛋白质。
本发明提供了一种上述枸杞细胞质抗坏血酸过氧化物酶基因LmAPX重组克隆载体pMD18-T-LmAPX。
本发明提供了一种上述枸杞细胞质抗坏血酸过氧化物酶基因LmAPX重组植物表达载体pCAMBIA2300- LmAPX。
含有上述的枸杞细胞质抗坏血酸过氧化物酶基因LmAPX的重组载体,这些重组载体包括质粒。
所述的质粒表达载体大肠杆菌表达载体pET28a-LmAPX。
所述的质粒表达载体双元植物表达载体pCAMBIA2300- LmAPX。
含有上述枸杞细胞质抗坏血酸过氧化物酶基因LmAPX完整编码阅读框序列的宿主细胞,如含有上述重组载体的宿主细胞也属于本发明的保护范围。
所述的宿主细胞选自大肠杆菌细胞、农杆菌细胞或烟草细胞。
本发明提供了一种含有LmAPX基因工程菌。
上述枸杞细胞质抗坏血酸过氧化物酶基因LmAPX的应用包括该LmAPX基因编码的蛋白在大肠杆菌和植物中的应用;
本发明的技术方案具体概述如下:
本发明提供的一种枸杞细胞质抗坏血酸过氧化物酶基因LmAPX,如序列表中SEQ ID NO.1所示的核苷酸序列,还包括所示的核苷酸序列添加、取代、插入或缺失一个或多个核苷酸的70%以上同源序列或者其等位基因及其衍生的核苷酸序列。
本发明提供的一种枸杞细胞质抗坏血酸过氧化物酶基因LmAPX编码的蛋白,如序列表SEQ ID NO.2所示氨基酸序列。
本发明的克隆方法由下述步骤组成:
从枸杞叶片中提取总RNA,根据NCBI中已登录的番茄(DQ096286)、辣椒(DQ002888)、马铃薯(AB041343)、烟草(U15933)的保守核苷酸序列分别从5’端和中间保守区域设计上游简并引物APX-JF:5’-CAATTRCTATGGGTAAGT-3’和中间特异性上游引物APX-BF:5’-AGGATATTGTTGCACTCTCTGGTG-3’。中间特异上游引物APX-BF与3' RACE试剂盒中下游Outer引物利用RACE技术扩增得到其3’端末端全长序列;同时根据已获得的3’端序列设计下游特异性引物,通过PCR扩增获得LmAPX基因的全长序列。
本发明构建含枸杞细胞质抗坏血酸过氧化物酶基因LmAPX的大肠杆菌表达载体pET28a-LmAPX,由下述步骤组成:
设计由SEQ ID NO.3所示的上游引物P1(P1:5’-ATGGGTAAGT GCTATCCT-3’),和由SEQ ID NO.4所示的下游引物P2(P2:5’-GCCACTACTCCCACCCT-3’),以枸杞细胞质抗坏血酸过氧化物酶基因LmAPX的cDNA为模板,进行PCR扩增,将PCR扩增产物连接于pMD18-T载体,获得含有序列表中SEQ ID NO.1所示的LmAPX基因的中间载体pMD18-T-LmAPX。
设计由SEQ ID NO.5所示的上游引物P3(P3:5’-CGCGGATCCATGGGTAAGTGCTATCCTA-3’),和由SEQ ID NO.6所示的下游引物P4(P4:5’-ACGCGTCGACCACCCTTCAGAATCACCAT-3’),以质粒pMD18-T-LmAPX为模板,进行PCR扩增,将PCR扩增产物经BamHI和SalI酶切后,将大肠杆菌表达载体pET28a经BamHI和SalI双酶切,二者进行连接反应,得到大肠杆菌表达载体pET28a-LmAPX。
本发明提供了一种枸杞细胞质抗坏血酸过氧化物酶基因及包括该基因的重组载体和宿主细胞及应用,首次从枸杞中分离出编码细胞质抗坏血酸过氧化物酶基因的完整cDNA,连接到大肠杆菌表达载体上,利用外源表达系统验证枸杞LmAPX基因在蛋白水平表达的产物具有酶的活性。
本发明通过提取新鲜枸杞叶片总RNA,用3'-RACE技术克隆了枸杞细胞质抗坏血酸过氧化物酶基因LmAPX,得到完整的编码基因序列为753bp。构建了大肠杆菌表达载体pET28a-LmAPX,对克隆的枸杞细胞质抗坏血酸过氧化物酶基因LmAPX编码的酶活性进行了鉴定,通过pET-28a原核表达载体构建的重组蛋白在大肠杆菌中异源表达表明LmAPX重组蛋白对底物抗坏血酸(AsA)和H2O2都具有较高的活性。同时构建了双元植物表达载体 pCAMBIA2300-LmAPX,电击法将载体转入农杆菌C58细胞,用这种细胞转化烟草,得到转基因烟草,用于后续的逆境胁迫研究。
附图说明
图1 pMD18-T-LmAPX载体示意图。
图2 pET28a-LmAPX载体示意图。
图3 pET28a-LmAPX酶切验证结果。
图4 LmAPX重组蛋白在大肠杆菌中表达的SDS-PAGE电泳图。
图5 双倒数法求LmAPX基因重组蛋白的Km和Vm值。(a)、(b)分别以AsA和H2O2为底物双倒数法作图。
图6 pCAMBIA2300-LmAPX载体示意图。
图7 pCAMBIA2300-LmAPX酶切验证结果。
图8转基因烟草基因组PCR验证结果。
具体实施方式
对本发明作进一步的阐述,实施例中未注明具体条件的实验方法,通常按照常规条件以及手册中所述的条件,或按照制造厂商所建议的条件。
实施例1
枸杞细胞质抗坏血酸过氧化物酶基因LmAPX的克隆:
以RNeasy Plant Mini Kit (QIAGEN,German)试剂盒,从100mg新鲜枸杞叶片中提取Total RNA,根据NCBI中已登录的番茄(DQ096286)、辣椒(DQ002888)、马铃薯(AB041343)、烟草(U15933)的保守核苷酸序列分别从5’端和中间部分设计上游简并引物APX-JF:5’-CAATTRCTATGGGTAAGT-3’和中间特异性上游引物APX-BF:5’-AGGATATTGTTGCACTCTCTGGTG-3’。利用3'-FULL RACE Core Set Ver.2.0 (TaKaRa,Japan)试剂盒扩增得到完整的基因序列。具体步骤:
①以Total RNA为模板,使用3'RACE Adaptor引物进行反转录反应,合成1st Strand cDNA,反应体系如下:
RNA: 2μl
3' RACE Adaptor: 1μl
5×M-MLV Buffer: 2μl
2.5mM dNTP Mixture: 1μl
RNase Inhibitor: 0.25μl
Reverse Transcriptase M-MLV: 0.25μl
RNase Free dH2O: 3.5μl
反应条件:42℃,60min;70℃,15min。
②根据基因的上游引物与试剂盒提供的下游引物3' RACE out primer: 5’ -TACCGTCGTTCCACTAGTGATTT -3’,以1st Strand cDNA为模板,进行PCR反应,反应体系如下:
1st PCR产物: 1μl
2.5mM dNTP Mixture: 2μl
APX-BF: 0.5μl
3' RACE out primer: 0.5μl
10×LA PCR Buffer: 2.5μl
TaKaRa LA Taq: 0.25μl
ddH2O: 18.25μl
Total volume 25μL
反应条件:94℃,4min;94℃,30sec;55℃,30sec;72℃,1min;72℃,8min,30个循环。
1st PCR产物: 1μl
2.5mM dNTP Mixture: 4μl
P1: 1μl
P2: 1μl
10×LA PCR Buffer: 5μl
TaKaRa LA Taq: 0.5μl
ddH2O: 37.5μl
Total volume 50μL
反应条件:94℃,4min;94℃,30sec;55℃,30sec;72℃,1min;72℃,8min,30个循环。
实施例2
克隆载体pMD18-T-LmAPX的构建过程
将序列表所示的LmAPX基因与pMD18-T载体连接,反应体系如下:
目的PCR片段: 4μl
pMD18-T载体: 1μl
SolutionI: 5μl
反应条件:16℃,30min。连接产物转化E.Coli TOP10,涂布于含Amp抗性的LB平板。以目的基因为引物进行PCR(反应条件:94℃,4min;94℃,30sec;55℃,30sec;72℃,1min;72℃,8min,30个循环。)得到PCR产物,电泳条带正确,然后送华大基因公司测序,测序结果在NCBI中进行Blast,表明为该基因。
实施例3
大肠杆菌表达载体pET28a-LmAPX的构建过程
首先,以pMD18-T-LmAPX为模版,P3和P4分别为上下游引物用高保真Pfu 酶扩增LmAPX片段,其反应条件为94℃,4min;94℃,30sec;57℃,30sec;72℃,1min50sec;72℃,8min,32个循环。在P3中引入BamHI酶切位点(CGCGGATCC),在P4中引入SalI酶切位点(ACGCGTCGAC)。然后,PCR产物与pET28a质粒分别经BamHI和SalI双酶切,将二者酶切产物连接:22℃,2 hrs,连接(2 μl载体DNA,5μl外源DNA,2 μl 5×T4 buffer,1 μl T4 DNA连接酶)。连接产物转化E. coli BL21( DE3) 感受态细胞,涂布于含卡那霉素的LB平板。以目的基因为引物进行PCR得到约750 bp左右产物条带,酶切鉴定得到目的条带如图3所示,最后送华大基因测序公司测序,结果表明载体pET28a-LmAPX构建正确。
实施例4
LmAPX基因在大肠杆菌中的功能验证
(1)LmAPX在BL21中的诱导表达以及纯化,具体步骤为:
加入IPTG(终浓度为l mmol/L)于28℃诱导表达12h后,先取出lml菌液作为对照保存于4℃;剩下的用于后续细菌蛋白抽提和目的蛋白纯化。其中,细菌蛋白抽提试剂盒(Cat. No. CW0888)和Ni-Agarose His 标签蛋白纯化试剂盒(Cat. No. CW0009)均购于康为世纪公司。
取IPTG诱导前后保存的菌液、抽提的细菌总蛋白和纯化后的LmAPX蛋白进行SDS-PAGE电泳。结果如图4所示:1泳道是标准蛋白分子量Mrker;2泳道是IPTG诱导后的空载体pET-28a;3泳道是IPTG诱导前的重组载体pET-28a-LmAPX;4泳道是抽提的细菌总蛋白;5泳道是纯化后的LmAPX蛋白。结果表明,诱导的空载体没有目的条带,未诱导的重组蛋白目的蛋白的表达量比较低,为本底水平的表达,诱导后的重组蛋白的目的条带表达量较高,纯化后的目的蛋白条带单一,分子量大小约27KDa。
(2)LmAPX蛋白的酶学特性分析
3mL酶反应混合液(50 mmol/L PBS PH7.0,0.1 mmol/L EDTA,0.4 mmol/L AsA)中加入适量纯化后的蛋白,然后再加入0.16mmol/L H2O2启动反应,通过测定290nm吸收值变化大小来初步检验纯化后的蛋白是否有活性;
H2O2浓度过量(0.16mmol/L)时取不同浓度的AsA (0.1、0.2、0.4、0.5、0.75、1.0 mmol/L),测定2min内A290的降低(每20s记录读数),反应以加入H2O2为起始。
AsA浓度过量(0.4mmol/L)时取不同浓度的H2O2 (0.12、0.2、0.3、0.4、0.8 mmol/L),测定2min内A290的降低(每20s记录读数),反应以加入H2O2为起始。
用酶促反应的速度的倒数(l/V)对底物浓度的倒数(1/[S])的作图。x和y轴上的截距分别代表米氏常数的倒数l/Km和最大反应速度的倒数1/Vm。公式为:l/V=Km/Vm×1/[S」+1/Vm,分别对两个底物AsA和H2O2双倒数法作图。如图5所示,pET28a-LmAPX重组蛋白在大肠杆菌中异源表达表明该重组蛋白对底物抗坏血酸(AsA)和H2O2都具有较高的活性。在AsA的浓度过量时,对H2O2的Km和Vmax分别是0.17± 0.02 mM 和11.78±1.88 mmol/min mg,在H2O2的浓度过量时,对AsA的Km和Vmax分别是2.19 ± 0.40 mM 和58.82 ±3.51 mmol/min mg。
实施例5
双元植物表达载体pCAMBIA2300-LmAPX的构建及转化农杆菌工程菌种C58
pET28a-LmAPX质粒和pCAMBIA2300空载体质粒分别经BamHI和SalI双酶切,酶切体系为:60μl质粒,2μl BamHI内切酶,2μl SalI内切酶,20μl 10×FastDigest Buffer,116μl ddH2O2,反应条件为37℃,3hrs。分别切胶回收目的片段LmAPX和载体片段pCAMBIA2300,然后将二者连接,连接体系同实施例3。连接产物转化E.Coli.TOP10,涂布于含100mg/L 浓度Kana抗性的LB平板。阳性克隆经酶切验证正确,如图7所示。构建成功的pCAMBIA2300-LmAPX载体通过电击转化农杆菌工程菌C58,通过菌落PCR验证正确的阳性转化子存于-80℃,用于后续的植物转基因。
实施例6
农杆菌感受态细胞的制备和电转化过程
(1)将根癌农杆菌C58活化,划板,28℃培养2天后长出单克隆。挑取单克隆接种于10 ml YEP液体培养基中,28℃振荡培养至对数期0D600=0.5。
(2)冰浴30 min,5000 rpm离心10 min,收集菌体。并用冰预冷的1 mmol/L的HEPES/KOH(pH7.0) 溶液重悬,并重复以上步骤2~3次。
(3)将农杆菌重悬于20 ml 预冷的10%甘油中,分装成每管100 μl预冷过的1.5 ml离心管中,液氮速冻,存于-80℃备用。
电击转化过程(冰上操作)
(1) 向含有100 μl感受态农杆菌中加入1μl质粒(约100ng),轻轻混合后冰浴1 min
(2) 转移到冰预冷的电击杯中(电击杯直径型号为1mm),电击转化。电击条件为:1.5 KV,200Ω,25 μF。
(3) 立即加入0.5 ml 不含抗生素的YEP培养基,28℃ 180 rpm,培养2~4 h。
(4) 直接取50 μl 转化后的菌液涂布于含卡那霉素的YEP平板上,28℃暗培养2~3 d。挑取单菌落做菌落PCR验证阳性克隆。
实施例7
农杆菌介导的烟草遗传转化
本实验用到的培养基:
无菌苗培养基:MS固体培养基,pH5.8;
侵染培养基:MS液体培养基,pH5.8;
共培培养基:MS+1mg/L6-BA+0.1mg/LNAA
脱菌筛选培养基:MS+1mg/L6-BA+0.1mg/LNAA+100mg/L卡那霉素+400mg/L的头孢霉素,pH5.8;
抗性苗生根培养基:MS+100 mg/卡那霉素+400mg/l的头孢霉素,pH5.8;
挑取阳性农杆菌单菌落,接种到5ml含100mg/L卡那霉素的YEP液体培养基中,于28℃、200r/min的摇床上过夜培养。
次日,取3ml菌液,接种到含100mg/L卡那霉素的50mlYEP液体培养基中,当菌液处于旺盛生长期(OD600=0.6-0.9)时,将菌液倒入50ml离心管,在3500r/min,4℃下离心15min,弃上清液,收集菌体。
将烟草叶片去除主脉和叶边缘,然后将叶片切成0.5×0.5cm大小,浸入制备好的农杆菌菌液,浸泡15-20min,其间摇动2-3次,使叶片充分接触菌液,取出叶片,用无菌的滤纸吸净多余的菌液,叶面朝下、叶背朝上接种于共培培养基中,25℃左右暗培养2天。
将根系生长良好、生命力旺盛的烟草组培苗从组培瓶中取出,用自来水冲洗培养基(尽量减少根系损伤),种植在营养土:蛭石:珍珠岩=4:5:1的培养土中,覆盖薄膜保温保湿15天,然后揭开薄膜,定期浇水、施肥,使之在温室中正常生长。
取上述PCR产物5μl进行电泳检测,图8说明LmAPX基因已成功转入烟草。
序列表
<110> 天津大学
<120> 枸杞细胞质抗坏血酸过氧化物酶基因及应用
<130> 2013420
<160> 6
<170> PatentIn version 3.3
<210> 1
<211> 965
<212> DNA
<213> 人工系列
<220>
<221> gene
<222> (1)..(965)
<400> 1
atgggtaagt gctatcctac cgtgagcgag gagtacctca aggctgttga caaatgtaaa 60
aggaaactca gaggactcat tgctgagaag aattgtgctc ctattatgct ccgtcttgca 120
tggcactctg ctggtacgta tgatgtgtgt tccaaaactg gaggtccttt cggtaccatg 180
aggttcaaag ctgaacaagg acatggagca aacaatggtc ttgacattgc tctgagactc 240
ttggagccca ttagggagca gtttcctatc ctctcccatg ctgatttcta ccaattggct 300
ggtgtcgttg ctgttgaagt tactggagga cctgatgttc cctttcaccc tggtagagag 360
gacaagccag aaccacctgt tgaaggtcgc ttgcctgatg ccaccaaggg ctgtgaccac 420
ttgagggatg tgttcgtgaa acaaatgggc ctttctgaca aggatattgt tgcgctctct 480
ggtgcccata ccttgggaag gtgccacaag gagcggtctg gttttgaggg accttggact 540
gccaatcccc ttgtctttga caactcatac tttaaggaac ttttgagtgg tgaaaaggaa 600
gggcttctgc agttgccatc agacaaggct ctactctgtg atcccgcttt ccgtcccctt 660
gttgagaaat atgctgcgga tgaagatgcc ttctttgctg actatgccga ggctcacttg 720
aagctctgtg aattggggtt tgctgaagct taagatggtg attctgaagg gtgggagtag 780
tggcttgttt ttgtttatgt ttcacttttg aaaagctagc tggagttgtt ggattttgtc 840
ttcttttgct gctcttacat catgatataa atttggcagc tatattagac gattatattg 900
tcactctctt ccagcttaat aagtttctat ttcctttttg ataaaaaaaa aaaaaaaaaa 960
aaaaa 965
<210> 2
<211> 250
<212> PRT
<213> 人工系列
<400> 2
Met Gly Lys Cys Tyr Pro Thr Val Ser Glu Glu Tyr Leu Lys Ala Val
1 5 10 15
Asp Lys Cys Lys Arg Lys Leu Arg Gly Leu Ile Ala Glu Lys Asn Cys
20 25 30
Ala Pro Ile Met Leu Arg Leu Ala Trp His Ser Ala Gly Thr Tyr Asp
35 40 45
Val Cys Ser Lys Thr Gly Gly Pro Phe Gly Thr Met Arg Phe Lys Ala
50 55 60
Glu Gln Gly His Gly Ala Asn Asn Gly Leu Asp Ile Ala Leu Arg Leu
65 70 75 80
Leu Glu Pro Ile Arg Glu Gln Phe Pro Ile Leu Ser His Ala Asp Phe
85 90 95
Tyr Gln Leu Ala Gly Val Val Ala Val Glu Val Thr Gly Gly Pro Asp
100 105 110
Val Pro Phe His Pro Gly Arg Glu Asp Lys Pro Glu Pro Pro Val Glu
115 120 125
Gly Arg Leu Pro Asp Ala Thr Lys Gly Cys Asp His Leu Arg Asp Val
130 135 140
Phe Val Lys Gln Met Gly Leu Ser Asp Lys Asp Ile Val Ala Leu Ser
145 150 155 160
Gly Ala His Thr Leu Gly Arg Cys His Lys Glu Arg Ser Gly Phe Glu
165 170 175
Gly Pro Trp Thr Ala Asn Pro Leu Val Phe Asp Asn Ser Tyr Phe Lys
180 185 190
Glu Leu Leu Ser Gly Glu Lys Glu Gly Leu Leu Gln Leu Pro Ser Asp
195 200 205
Lys Ala Leu Leu Cys Asp Pro Ala Phe Arg Pro Leu Val Glu Lys Tyr
210 215 220
Ala Ala Asp Glu Asp Ala Phe Phe Ala Asp Tyr Ala Glu Ala His Leu
225 230 235 240
Lys Leu Cys Glu Leu Gly Phe Ala Glu Ala
245 250
<210> 3
<211> 18
<212> DNA
<213> 人工系列
<220>
<221> gene
<222> (1)..(18)
<400> 3
atgggtaagt gctatcct 18
<210> 4
<211> 17
<212> DNA
<213> 人工系列
<220>
<221> gene
<222> (1)..(17)
<400> 4
gccactactc ccaccct 17
<210> 5
<211> 28
<212> DNA
<213> 人工系列
<220>
<221> gene
<222> (1)..(28)
<400> 5
cgcggatcca tgggtaagtg ctatccta 28
<210> 6
<211> 29
<212> DNA
<213> 人工系列
<220>
<221> gene
<222> (1)..(29)
<400> 6
acgcgtcgac cacccttcag aatcaccat 29 。
序列表
<110> 天津大学
<120> 枸杞细胞质抗坏血酸过氧化物酶基因及应用
<130> 2013420
<160> 6
<170> PatentIn version 3.3
<210> 1
<211> 965
<212> DNA
<213> 人工系列
<220>
<221> gene
<222> (1)..(965)
<400> 1
atgggtaagt gctatcctac cgtgagcgag gagtacctca aggctgttga caaatgtaaa 60
aggaaactca gaggactcat tgctgagaag aattgtgctc ctattatgct ccgtcttgca 120
tggcactctg ctggtacgta tgatgtgtgt tccaaaactg gaggtccttt cggtaccatg 180
aggttcaaag ctgaacaagg acatggagca aacaatggtc ttgacattgc tctgagactc 240
ttggagccca ttagggagca gtttcctatc ctctcccatg ctgatttcta ccaattggct 300
ggtgtcgttg ctgttgaagt tactggagga cctgatgttc cctttcaccc tggtagagag 360
gacaagccag aaccacctgt tgaaggtcgc ttgcctgatg ccaccaaggg ctgtgaccac 420
ttgagggatg tgttcgtgaa acaaatgggc ctttctgaca aggatattgt tgcgctctct 480
ggtgcccata ccttgggaag gtgccacaag gagcggtctg gttttgaggg accttggact 540
gccaatcccc ttgtctttga caactcatac tttaaggaac ttttgagtgg tgaaaaggaa 600
gggcttctgc agttgccatc agacaaggct ctactctgtg atcccgcttt ccgtcccctt 660
gttgagaaat atgctgcgga tgaagatgcc ttctttgctg actatgccga ggctcacttg 720
aagctctgtg aattggggtt tgctgaagct taagatggtg attctgaagg gtgggagtag 780
tggcttgttt ttgtttatgt ttcacttttg aaaagctagc tggagttgtt ggattttgtc 840
ttcttttgct gctcttacat catgatataa atttggcagc tatattagac gattatattg 900
tcactctctt ccagcttaat aagtttctat ttcctttttg ataaaaaaaa aaaaaaaaaa 960
aaaaa 965
<210> 2
<211> 250
<212> PRT
<213> 人工系列
<400> 2
Met Gly Lys Cys Tyr Pro Thr Val Ser Glu Glu Tyr Leu Lys Ala Val
1 5 10 15
Asp Lys Cys Lys Arg Lys Leu Arg Gly Leu Ile Ala Glu Lys Asn Cys
20 25 30
Ala Pro Ile Met Leu Arg Leu Ala Trp His Ser Ala Gly Thr Tyr Asp
35 40 45
Val Cys Ser Lys Thr Gly Gly Pro Phe Gly Thr Met Arg Phe Lys Ala
50 55 60
Glu Gln Gly His Gly Ala Asn Asn Gly Leu Asp Ile Ala Leu Arg Leu
65 70 75 80
Leu Glu Pro Ile Arg Glu Gln Phe Pro Ile Leu Ser His Ala Asp Phe
85 90 95
Tyr Gln Leu Ala Gly Val Val Ala Val Glu Val Thr Gly Gly Pro Asp
100 105 110
Val Pro Phe His Pro Gly Arg Glu Asp Lys Pro Glu Pro Pro Val Glu
115 120 125
Gly Arg Leu Pro Asp Ala Thr Lys Gly Cys Asp His Leu Arg Asp Val
130 135 140
Phe Val Lys Gln Met Gly Leu Ser Asp Lys Asp Ile Val Ala Leu Ser
145 150 155 160
Gly Ala His Thr Leu Gly Arg Cys His Lys Glu Arg Ser Gly Phe Glu
165 170 175
Gly Pro Trp Thr Ala Asn Pro Leu Val Phe Asp Asn Ser Tyr Phe Lys
180 185 190
Glu Leu Leu Ser Gly Glu Lys Glu Gly Leu Leu Gln Leu Pro Ser Asp
195 200 205
Lys Ala Leu Leu Cys Asp Pro Ala Phe Arg Pro Leu Val Glu Lys Tyr
210 215 220
Ala Ala Asp Glu Asp Ala Phe Phe Ala Asp Tyr Ala Glu Ala His Leu
225 230 235 240
Lys Leu Cys Glu Leu Gly Phe Ala Glu Ala
245 250
<210> 3
<211> 18
<212> DNA
<213> 人工系列
<220>
<221> gene
<222> (1)..(18)
<400> 3
atgggtaagt gctatcct 18
<210> 4
<211> 17
<212> DNA
<213> 人工系列
<220>
<221> gene
<222> (1)..(17)
<400> 4
gccactactc ccaccct 17
<210> 5
<211> 28
<212> DNA
<213> 人工系列
<220>
<221> gene
<222> (1)..(28)
<400> 5
cgcggatcca tgggtaagtg ctatccta 28
<210> 6
<211> 29
<212> DNA
<213> 人工系列
<220>
<221> gene
<222> (1)..(29)
<400> 6
acgcgtcgac cacccttcag aatcaccat 29 。
Claims (9)
1.一个枸杞细胞质抗坏血酸过氧化物酶基因,其特征在于该基因魏SEQ ID No.1所示的核苷酸序列。
2.权利要求1所述的枸杞细胞质抗坏血酸过氧化物酶基因编码的蛋白质,其特征在于所述的蛋白质具有SEQ ID No.2所示的氨基酸序列。
3.一种重组载体,其特征在于含有权利要求1所述的枸杞细胞质抗坏血酸过氧化物酶基因全序列或部分片段。
4.一种权利要求3所述的重组载体,其特征在于它是质粒表达载体大肠杆菌表达载体pET28a-LmAPX。
5.一种权利要求3所述的重组载体,其特征在于它是重组载体的大肠杆菌BL21。
6.一种权利要求3所述的重组载体,其特征在于它是重组植物表达载体pCAMBIA2300- LmAPX。
7.一种宿主细胞,其特征在于含有权利要求1所述的枸杞细胞质抗坏血酸过氧化物酶基因全序列或部分片段。
8.一种权利要求7所述的宿主细胞,其特征在于它是大肠杆菌细胞、农杆菌细胞、烟草细胞、玉米细胞或者大豆细胞。
9.一种权利要求1所述的枸杞细胞质抗坏血酸过氧化物酶基因(LmAPX)的应用,其特征在于它用于制备转基因玉米、大豆、水稻、花生、向日葵、马铃薯、棉花、谷子、大麦以及花卉和蔬菜植株。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101739853A CN103305538A (zh) | 2013-05-13 | 2013-05-13 | 枸杞细胞质抗坏血酸过氧化物酶基因及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101739853A CN103305538A (zh) | 2013-05-13 | 2013-05-13 | 枸杞细胞质抗坏血酸过氧化物酶基因及应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103305538A true CN103305538A (zh) | 2013-09-18 |
Family
ID=49131258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013101739853A Pending CN103305538A (zh) | 2013-05-13 | 2013-05-13 | 枸杞细胞质抗坏血酸过氧化物酶基因及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103305538A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103757034A (zh) * | 2013-11-11 | 2014-04-30 | 天津大学 | 用于改善植物抗逆性的枸杞ggps1基因及该基因的重组载体 |
CN106754990A (zh) * | 2016-12-23 | 2017-05-31 | 河北农业大学 | 棉花抗坏血酸过氧化物酶基因apx及其应用 |
CN109971731A (zh) * | 2019-05-10 | 2019-07-05 | 中国科学院华南植物园 | 一种抗坏血酸过氧化物酶突变体MaAPX1M36K及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102161996A (zh) * | 2011-03-01 | 2011-08-24 | 洪洞县维民生生物科技有限公司 | 枣树抗坏血酸过氧化物酶基因及其在提高植物抗逆性中的应用 |
-
2013
- 2013-05-13 CN CN2013101739853A patent/CN103305538A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102161996A (zh) * | 2011-03-01 | 2011-08-24 | 洪洞县维民生生物科技有限公司 | 枣树抗坏血酸过氧化物酶基因及其在提高植物抗逆性中的应用 |
Non-Patent Citations (2)
Title |
---|
李泽琴等: "植物抗坏血酸过氧化物酶的表达调控以及对非生物胁迫的耐受作用", 《遗传》, vol. 35, no. 1, 31 January 2013 (2013-01-31), pages 45 - 54 * |
毛桂莲等: "外源Ca2+和H2O2对NaCl胁迫下枸杞离体叶片叶绿体中活性氧代谢的影响研究", 《干旱地区农业研究》, vol. 27, no. 5, 30 September 2009 (2009-09-30), pages 191 - 195 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103757034A (zh) * | 2013-11-11 | 2014-04-30 | 天津大学 | 用于改善植物抗逆性的枸杞ggps1基因及该基因的重组载体 |
CN103757034B (zh) * | 2013-11-11 | 2015-12-30 | 天津大学 | 用于改善植物抗逆性的枸杞ggps1基因及该基因的重组载体 |
CN106754990A (zh) * | 2016-12-23 | 2017-05-31 | 河北农业大学 | 棉花抗坏血酸过氧化物酶基因apx及其应用 |
CN109971731A (zh) * | 2019-05-10 | 2019-07-05 | 中国科学院华南植物园 | 一种抗坏血酸过氧化物酶突变体MaAPX1M36K及其应用 |
CN109971731B (zh) * | 2019-05-10 | 2019-11-15 | 中国科学院华南植物园 | 一种抗坏血酸过氧化物酶突变体MaAPX1M36K及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104212816B (zh) | 玉米锌铁调控转运体ZmZIPs基因及其应用 | |
CN114591969B (zh) | 一种抗旱基因CrWRKY57及其在植物抗旱改良中的应用 | |
CN108948164A (zh) | 甘薯耐盐抗旱相关蛋白IbbZIP1及其编码基因与应用 | |
CN103103166B (zh) | 植物耐逆性相关蛋白TaNCED1及其编码基因与应用 | |
Shahbazi et al. | Transgenic tobacco co-expressing flavodoxin and betaine aldehyde dehydrogenase confers cadmium tolerance through boosting antioxidant capacity | |
CN105368849A (zh) | 具有抗逆功能的枸杞9-顺式环氧类胡萝卜素双氧合酶基因及应用 | |
CN103194466A (zh) | 一种岷江百合谷胱甘肽S-转移酶基因LrGSTU5及其应用 | |
CN105524156A (zh) | 抗逆相关基因ZmHDZIV14在调控植物抗逆性中的应用方法 | |
CN105198976A (zh) | 一种与植物抗逆性相关蛋白GsERF6及其编码基因与应用 | |
CN103305538A (zh) | 枸杞细胞质抗坏血酸过氧化物酶基因及应用 | |
CN101691573B (zh) | 一种腊梅分泌性过氧化物酶的基因、蛋白及其应用 | |
CN104829699B (zh) | 一种与植物抗逆性相关蛋白Gshdz4及其编码基因与应用 | |
CN101139385B (zh) | 一种植物抗逆性相关蛋白及其编码基因与应用 | |
CN104212814A (zh) | 玉米锌铁调控转运体ZmZIP4和ZmZIP6基因及其应用 | |
CN107663232B (zh) | 植物抗逆相关蛋白OsIAA18及其编码基因与应用 | |
CN110172088A (zh) | 蜡梅转录因子基因CpSNAC1及其应用 | |
CN111171124B (zh) | 一种植物抗逆性相关蛋白VvIAA18及编码基因与应用 | |
Xu et al. | Cloning and characterization of gene encoding a Mn-containing superoxide dismutase in Eutrema halophilum | |
CN103305485B (zh) | 植物耐逆性相关蛋白w106及其编码基因和应用 | |
US7655837B2 (en) | Glutathione-S-transferase gene from Proposis juliflora confers abiotic stress tolerance in plants | |
CN104212815B (zh) | 玉米锌铁调控转运体ZmIRT1基因及其应用 | |
CN103305484B (zh) | 植物耐逆性相关蛋白w69及其编码基因和应用 | |
CN108341861A (zh) | 一种来源于杜梨的抗病性相关基因及其编码蛋白与应用 | |
CN101851634B (zh) | 利用枳精氨酸脱羧酶基因PtADC提高植物抗旱耐寒能力 | |
CN102888402A (zh) | 玉米淹水胁迫响应zmERF2基因启动子的克隆及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130918 |